文献速递神经MR

弥散峰度成像评估胶质瘤:不同感兴趣区选择方法对时间效率、测量可重复性及诊断能力的影响

Diffusion kurtosis imaging in evaluating gliomas: different region of interest selection methods on time efficiency, measurement repeatability, and diagnostic ability.
PubMed 文献 · Eur Radiol · 2020-08-28

前瞻性纳入66例病理证实的胶质瘤患者(低级别36例,高级别30例),比较三种手动勾画感兴趣区(ROI)方法(十点法ROI-10s、三个最大肿瘤层面ROI-3s、全肿瘤实质ROI-whole)的观察者内一致性、耗时、诊断效能及生存分析。结果显示各ROI方法观察者内一致性均良好,ROI-10s耗时显著少于其他两种方法(p<0.001);ROI-10s在分级和预测IDH-1突变状态方面诊断价值略优于其他两种方法,在识别1p19q共缺失方面明显优于ROI-3s和ROI-whole;基于ROI-10s并纳入年龄和平均弥散率的生存模型预测价值最高(C-index 0.81)。

要点

  • 三种ROI方法观察者内一致性均良好,ROI-10s耗时显著少于ROI-3s和ROI-whole(p<0.001)。
  • ROI-10s在胶质瘤分级和预测IDH-1突变状态方面诊断价值略优于其他两种方法。
  • ROI-10s在识别1p19q共缺失方面明显优于ROI-3s和ROI-whole,综合评估胶质瘤诊断价值最佳。

核心结论

  • 在三种ROI方法中,ROI-10s耗时最少且对胶质瘤综合评估的诊断价值最佳,是处理DKI数据的有效方式,在胶质瘤临床评估中具有重要应用价值。

研究设计与样本

  • 前瞻性纳入66例病理证实的胶质瘤患者(低级别胶质瘤36例,高级别胶质瘤30例),其中女性29例,中位年龄45岁。
  • 所有患者均行DKI检查并生成各指标DKI图,由两名独立放射科医师手动勾画三组ROI:十点法(ROI-10s)、三个最大肿瘤层面(ROI-3s)和全肿瘤实质(ROI-whole)。
  • 分析三种ROI方法所得DKI指标的观察者间一致性、耗时、诊断效能及生存分析。

诊断标准与关键数值

  • 三种ROI方法所有参数的观察者内一致性均良好。
  • ROI-10s耗时显著少于其他两种方法(p<0.001)。
  • 基于ROI-10s的DKI在胶质瘤分级和预测IDH-1突变状态方面诊断价值略优于其他两种ROI方法。
  • 基于ROI-10s的DKI指标在识别1p19q共缺失方面明显优于ROI-3s和ROI-whole。
  • 生存分析中,基于ROI-10s并纳入患者年龄和平均弥散率的模型预测价值最高(C-index 0.81)。

临床应用与阅片要点

  • 作者认为ROI-10s是处理DKI数据的有效方式,在胶质瘤临床评估中具有重要应用价值。
  • 原文未据此给出具体阅片或报告操作推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Comparing the diagnostic efficacy of diffusion kurtosis imaging (DKI) derived from different region of interest (ROI) methods in tumor parenchyma for grading and predicting IDH-1 mutation and 1p19q co-deletion status of glioma patients and correlating with their survival data.

METHODS: Sixty-six patients (29 females; median age, 45 years) with pathologically proved gliomas (low-grade gliomas, 36; high-grade gliomas, 30) were prospectively included, and their clinical data were collected. All patients underwent DKI examination. DKI maps of each metric were derived. Three groups of ROIs (ten spots, ROI-10s; three biggest tumor slices, ROI-3s; and whole-tumor parenchyma, ROI-whole) were manually drawn by two independent radiologists. The interobserver consistency, time spent, diagnostic efficacy, and survival analysis of DKI metrics based on these three ROI methods were analyzed.

RESULTS: The intraexaminer reliability for all parameters among these three ROI methods was good, and the time spent on ROI-10s was significantly less than that of the other two methods (p < 0.001). DKI based on ROI-10s demonstrated a slightly better diagnostic value than the other two ROI methods for grading and predicting the IDH-1 mutation status of glioma, whereas DKI metrics derived from ROI-10s performed much better than those of the ROI-3s and ROI-whole in identifying 1p19q co-deletion. In survival analysis, the model based on ROI-10s that included patient age and mean diffusivity showed the highest prediction value (C-index, 0.81).

CONCLUSIONS: Among the three ROI methods, the ROI-10s method had the least time spent and the best diagnostic value for a comprehensive evaluation of glioma. It is an effective way to process DKI data and has important application value in the clinical evaluation of glioma.

KEY POINTS: • The intraexaminer reliability for all DKI parameters among different ROI methods was good, and the time spent on ROI-10 spots was significantly less than the other two ROI methods. • DKI metrics derived from ROI-10 spots performed the best in ROI selection methods (ROI-10s, ten-spot ROIs; ROI-3s, three biggest tumor slices ROI; and ROI-whole, whole-tumor parenchyma ROI) for a comprehensive evaluation of glioma. • The ROI-10 spots method is an effective way to process DKI data and has important application value in the clinical evaluation of glioma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Chu JP, Song YK, Tian YS, et al. Diffusion kurtosis imaging in evaluating gliomas: different region of interest selection methods on time efficiency, measurement repeatability, and diagnostic ability. Eur Radiol. 2020. PMID: 32857204. doi:10.1007/s00330-020-07204-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。